baber/WOPTO huggingface dataset:
Patent NZ-514736-A (NZ)
Title: Process for preparing amine platinum complexes
Inventor: WONG ERNEST S Y
IPC: A61K45/06
Filed: 2000-04-11
Abstract: Described is a process for preparing platinum complexes having general formula (Ia) or (Ib), comprising: 1a) a first step, wherein [PtA4]2- is reacted with L under appropriate conditions in a first solvent to form [PtA3(L)]-; 1b) a second step, wherein [PtA3(L)]- is reacted with L' under appropriate conditions in a second solvent to form cis-[(PtA2(L')(L)]; 1c) in the case there Y is halogen or hydroxy a third step, wherein cis-[PtA2 (L')(L)] is reacted with H2O2, Y2 or halogen containing oxidant to form c,t,c-[PtA2Y2(L')(L)]; in the case where Y is carboxylate, carbamate or carbonate ester a fourth step, wherein an intermediate, where Y is hydroxy formed in step 1c), is functionalised with an appropriate acylating agent; and 1d) in the case where A is not a halide or is different from the original halide, additional step(s) in which the original halide A of an intermediate formed in step 1a or 1b, 1c or 1d is converted to a different halide or a new leaving group(s) A such as mono-dentate hydroxy, alkoxy, carboxylate or bi-dentate carboxylate, phosphonocarboxylate, diphosphonate, or sulphate; wherein L, L' and Y have the meaning as defined in the description.
Patent NZ-515376-A (NZ)
Title: A locating key for a keyboard or keypad
Inventor: SABATO ALBERTO B
IPC: G06F3/02
Filed: 2000-06-21
Abstract: A key for a keyboard or keypad, the key having an upper finger  engaged  surface so as to have a  top  edge  portion remote from the user, a bottom edge portion adjacent to  the user,  a  left edge portion and a right edge portion.   Also described  is  a  Qwerty  keyboard  having  a  plurality  of alphanumeric  keys  with a variety of  different  ridges  on various parts of the keyboard.
Patent NZ-520725-A (NZ)
Title: Fire blanket
Inventor: CHATTAWAY ADAM
IPC: A62C8/06
Filed: 2001-02-09
Abstract: A fire blanket comprising a generally flexible substrate and a chemical compound which reacts endothermically when heated.  The chemical compound is preferably an alkali metal salt and more preferably a potassium or sodium salt.  The compound may be a solid at room temperatures or forms an alkali solution.
Patent NZ-522082-A (NZ)
Title: Device for carrying out work in an elevator shaft
Inventor: SCHNEIDER MARCEL
IPC: B66B5/00
Filed: 2000-04-20
Abstract: Device for carrying out wok in an elevator hoistway (1), in which an elevator car (2) can be caused to travel which has a maintenance platform (10) from which the work can be carried out, characterized in that the maintenance platform (10) is situated outside the area occupied by the users of the elevator car, and for the purpose of carrying out the work in the elevator hoistway (1) has a stage (12) within the elevator car (2) as a surface to stand on, the stage (12) being accessible from the area occupied by the users of the elevator car.
Patent NZ-522430-A (NZ)
Title: Perforation detection method
Inventor: JOLIC KARLO IVAN
IPC: G01M3/40
Filed: 2001-04-04
Abstract: A method of detecting perforations in a portion of a substantially electrically non-conducting package (1) which contains an electrically conducting material, the method comprising the steps of: (a) immersing the portion (2) of the package to be tested in an electrolyte solution (3); (b) contacting a substantial amount of non-immersed package surface with an electrical conductor (5); (c) electrically connecting a first terminal of an AC electrical power source (6) to the electrical conductor and a second terminal to the electrolyte solution and including a resistor (7) in an electrical connection either between the first terminal; and the electrical conductor or between the second terminal and the electrolyte solution; (d) measuring voltage reduction across the resistor or measuring current flow and comparing it with a threshold value such that if the voltage reduction or current exceeds the threshold value, perforation of the tested portion of the package is indicated.
Patent NZ-523028-A (NZ)
Title: Cannabinoid drugs for use in decreasing cell proliferation
Inventor: BURSTEIN SUMNER
IPC: A61K31/353
Filed: 2001-05-17
Abstract: The use of cannabinoid compounds (derivatives of tetrahydrocannabinol) for decreasing cell proliferation in a mammal is disclosed.
Patent NZ-524131-A (NZ)
Title: Ectpoic expression of the homeobox transcription factor Ath1 in genetically modified herbicide resistant grasses to delay, inhibit or reduce flowering
Inventor: VAN DER VALK PIETER
IPC: A01H5/00
Filed: 2001-08-16
Abstract: A grass which has been genetically modified with a sequence encoding a homeobox factor is described. The modified grass comprises substantial inhibition of generative propagation without evidencing a negative phenotype and is modified with at least one trait providing resistance to a herbicide and wherein the grass is herbicide resistant. Preferably the modification is ectopic expression of transcription factor AtH1.
Patent NZ-525599-A (NZ)
Title: Protective beacon for airport fueling systems
Inventor: LEIGH MICHAEL
IPC: B64F1/20
Filed: 2001-10-30
Abstract: A portable beacon (8) for deterring damaging access to a deactivatable hazard such as the refueling valve of the apron refueling system at an airport, comprises means for deactivating the hazard in the event of actual or impending damaging access to the hazard, and proximity sensors that determine the distance of the threat from the hazard so that first a warning might be generated and as the hazard comes closer to the fuel valve that the beacon is protecting, the valve is deactivated by the action of the beacon.
Patent NZ-526454-A (NZ)
Title: Advanced sulfosuccinamate surfactants
Inventor: SMITH GEORGE A
IPC: C11D1/12
Filed: 2001-12-18
Abstract: A composition of matter useful as a surfactant in finished formulations for cleaning dishes, hard surfaces, and laundry, comprising an anionic form of a material described by formula (I) in which, R1 is a hydrocarbyl group containing between 5 and 19 carbon atoms, saturated or unsaturated, straight-chain, branched, or cyclic; R2 and R3 may each independently be a hydrogen, or a hydrocarbyl group selected from the group consisting of: methyl and ethyl; x may be any integer between 1 and 20, including 1 and 20; R4 and R5 may each independently be a hydrogen, or a hydrocarbyl group selected from the group consisting of: methyl and ethyl; and y is independently equal to zero or 1.
Patent NZ-527448-A (NZ)
Title: Adjustable mold for forming shaped foods
Inventor: GROOTE JAN-HENDRIK DE
IPC: A21B3/13
Filed: 2003-08-07
Abstract: An adjustable mould for forming shaped foods. The mould includes an upper section comprising a primary moulding chamber and a lower section comprising a secondary moulding chamber, with a folded area joining the walls of the upper and lower sections, the lower section and the secondary moulding chamber being selectively invertible between a first extended position aligned with and depending below the primary moulding chamber, and a second adjusted position upwardly inverted about the folded area and projecting into primary moulding chamber.
Patent NZ-527756-A (NZ)
Title: Livestock feed supplement comprising a tannin containing material and a flavonoid containing material
IPC: A23K1/14
Filed: 2003-08-25
Abstract: Disclosed is a feed additive particularly suitable for livestock, comprising a tannin-containing material, and a flavonoid-containing material. In particular, the tannin- and flavonoid-containing materials are derived from plants. The tannin containing material may be derived from plants selected from the genera Aesculus, Castanea, Quercus, Juglans, Ceratonia, Quillaja, Vitis and/or Camellia. The flavonoid-containing material may be derived from plants selected from one or more of plants selected citrus fruits and grapes. The additive is designed to be added to animal feed mixture, and may also include carriers acceptable for the use in such feeds. Such additives are useful in the promotion of health in livestock.
Patent NZ-528739-A (NZ)
Title: A mutant human hepatitis B viral strain and uses thereof
Inventor: OON CHONG JIN
IPC: C12N15/51
Filed: 1998-06-19
Abstract: An isolated strain of Hepatitis B virus designated Human Hepatitis B Virus Surface Antigen-'S'-133 Oon Strain (Methionine to Threonine). Also, an isolated nucleic acid encoding a polypeptide which is a mutant major surface antigen of a strain of hepatitis B virus, such polypeptide having an amino acid sequence which differs from the amino acid sequence of a major surface antigen of a wild type hepatitis B virus in that the amino acid at position number 133 of such polypeptide is a threonine rather than methionine. Such nucleic acids are useful for determining whether a patient is infected with the said strain, wherein diagnosis involves testing a nucleic acid sample for the presence of a nucleic acid encoding a protein as discussed above. (62) Divided out of 508890
Patent NZ-529504-A (NZ)
Title: An inhalation device
Inventor: ASKING LARS
IPC: A61M15/00
Filed: 2002-05-21
Abstract: An inhalation device for delivery of a powdered medicament comprising a suction tube (21) and one or more doses of powdered medicament. The suction tube has a distal end (28) and a proximal end (29) with an air passage (30) therethrough, the distal end having an air inlet and the proximal end having an air outlet which forms the mouthpiece of the device. The inhalation device further comprises a means for drying air (23) drawn by a user into the inhalation device prior to contact with the aggregated powdered medicament such that a dose of powdered medicament will be dispersed in dried air for delivery at the proximal end. The means for drying air is located outside the suction tube so that the air is dried prior to entering the air inlet.
Patent NZ-530544-A (NZ)
Title: Plastics article with low thermal conductivity, high light transmittance and absorption in the near infrared region
Inventor: GROOTHUES HERBERT
IPC: B32B27/18
Filed: 2002-07-17
Abstract: The invention relates to a plastic body consisting of a base moulded body which is produced from a transparent, thermoplastic base material, and which consists of at least two opposing flat layers (1a, 1b) which are interconnected by means of vertical or diagonal connecting elements (2). One of the flat layers (1a) is provided with an additional layer (3) consisting of a plastic matrix in a transparent, plastic base material. The invention is characterised in that the additional layer (3) is an IR-absorbent layer containing at least one IR-absorber which does not impair the transparency of the plastic body and has an average transmission of less than 80 % in the region of the near-infrared radiation (780 nm to 1100 nm). The plastic body has a light transmission (D65) of between 15 % and 86 %, a maximum heat transition coefficient of 4 W/m<2>K and a minimum Sk value of 1.15. The invention also relates to the use of said plastic body as a glazing element, a roofing element or a heat insulating element.
Patent NZ-532715-A (NZ)
Title: Wheelchair suspension
Inventor: MOLNAR JAMES H
IPC: B60K6/00
Filed: 2002-09-20
Abstract: A plurality of pivoting linkages to lift and retract a front castor assembly to facilitate traversing an obstacle or rough terrain. In this regard, a wheelchair suspension having a frame member and at least one a pivoting assembly is provided. The pivoting assembly has, for example, a first linkage pivotally coupled to the frame member and a second linkage pivotally coupled to the frame member. A drive assembly is coupled to the first linkage. At least one front caster assembly is coupled to the first and second linkages wherein upward pivotal movement of the first and second linkages causes the caster assembly to undergo upward lateral movement toward the drive assembly.
Patent NZ-533313-A (NZ)
Title: Adhesive-edge building panel and method of manufacture
Inventor: PENG WEILING
IPC: B60J10/00
Filed: 2002-11-25
Abstract: Disclosed herein is an adhesive-edge building panel used in the fabrication of interior or exterior construction panels of a wall systems of with elastomeric joints that are resistant to cracking. The panels are preferably fiber cement. An adhesive is pre-applied adjacent to an edge of the panel and laminated to a release liner. Panels are fastened to a frame with the adhesive-edges adjacent to each other. A backing material is applied to the seam between the panels such that the edges of the joint tape adhere to the adhesive-edges of the adjacent panels. The wall is then finished with an elastomeric finish. Also disclosed is a method of manufacturing the adhesive-edge panels.
Patent NZ-534919-A (NZ)
Title: Bioactive keratin peptides
Inventor: COWSAR DONALD R
IPC: A61L27/22
Filed: 2003-01-28
Abstract: An isolated bioactive peptide and compositions that comprise said peptide for pharmaceutical or topical administration or for use in cosmetic preparations.
Patent NZ-537512-A (NZ)
Title: Oligosaccharide biomarkers for mucopolysaccharidoses and other related disorders
Inventor: MEIKLE PETER JOHN
IPC: G01N33/53
Filed: 2003-06-13
Abstract: Methods for diagnosing mucopolysaccharidoses ("MPS") and related diseases. This invention pertains to methods for identifying and quantitating biochemical markers ("biomarkers") that are present in biological fluids or tissues of a patient having a MPS or related disorder. One aspect of the method comprises determining a target quantity of a target MPS biomarker oligosaccharide from a target biological sample taken from the target animal, and then comparing the target quantity to a reference quantity of a reference MPS biomarker oligosaccharide for the diagnosis, characterization, monitoring , and clinical management of MPS and related disease. This invention also describes a kit comprising a oligosaccharide derivatization solution; an acid solution; an internal standard; a solid phase extraction column; a solid phase extraction column wash solution; an oligosaccharide elution solution; and a set of instructions for using the kit to diagnose a MPS or related disease.
Patent NZ-538932-A (NZ)
Title: 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative disease
Inventor: MARSHALL DANIEL R
IPC: C07D401/12
Filed: 2003-08-12
Abstract: Disclosed are compounds of formula I wherein the substituents are as defined in the specification, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function (such as type II diabetes) or characterised by inflammatory, allergic, or proliferative processes (such as lung diseases) in a non-human mammalian subject using these compounds.
Patent NZ-544309-A (NZ)
Title: Variable pump
Inventor: WIGGINS STEVEN JOHN
Filed: 2005-12-21
Abstract: A centrifugal pump 20 includes a pump housing 24 and an impeller 26. One or more grooves 29 are provided in the housing 24 adjacent the impeller 26 to removably receive a cutwater 28. The groove or grooves 29 is/are adapted to interchangeably receive cutwaters 28 of different sizes.
Patent NZ-545201-A (NZ)
Title: Method and apparatus for tracking a load on a conveyor system
Inventor: LEVASSEUR BRIAN C
IPC: B65G43/10
Filed: 2004-07-29
Abstract: A method and apparatus for tracking a load on a conveyor system using only the trailing edge of the load are disclosed. The method includes the steps of sensing only the trailing edge of the load with a first sensor and updating a load record for the load in response to sensing the trailing edge of the load with the first sensor. The apparatus may include a conveyor, a controller, and a sensor in communication with the controller for sensing only the trailing edge of a load on the conveyor.
Patent NZ-546328-A (NZ)
Title: Laundry machine with lost motion clutch
Inventor: SEAGAR NEVILLE DAVID
Filed: 2006-03-31
Abstract: A laundry machine with a lost motion clutch is disclosed. A spin basket (122) is located in a tub (120) of the machine. The machine includes a drive assembly with a shaft (128) and agitator (124), where the shaft passes through a wall of the spin basket and the agitator is located within the spin basket. The lost motion clutch (142) is physically located in the tub and interconnects between the drive assembly and the spin basket, and absorbs greater than one revolution of relative rotation.
Patent NZ-546692-A (NZ)
Title: Pharmaceutical composition containing fenofibrate and method for the preparation thereof
Inventor: CRIERE BRUNO
IPC: A61K9/16
Filed: 2004-10-01
Abstract: Disclosed is the use of a composition of fenofibrate containing micronized fenofibrate, a surfactant and a binding cellulose derivative as a solubilization adjuvant, said composition containing an amount of fenofibrate greater than or equal to 60% by weight for the preparation of a medicament for treating hypertriglyceridemias, hypercholesterolemias or hyperlipidemias while reducing the food effect on the bioavailability of fenofibrate, wherein said composition is in the form of granules comprising: (d) a neutral core; (e) an active layer, which surrounds the core; and (f) an outer layer; wherein said active layer comprises micronized fenofibrate, a surfactant and a binding cellulose derivative; and wherein said formulation has a dissolution profile of less than 10% at 5 minutes and more than 80% at 20 minutes according to the European Pharmacopoeia in a dissolution medium constituted by water with 0.025 M sodium lauryl sulphate.
Patent NZ-547266-A (NZ)
Title: Anti-IGFR1 antibody in combination with chemotherapeutic agents
Inventor: WANG YAN
IPC: C07K16/28
Filed: 2004-11-19
Abstract: Disclosed is a combination comprising: (a) one or more isolated anti-IGFR1 antibodies or antigen-binding fragments thereof comprising a member selected from the group consisting of: a light chain immunoglobulin amino acid sequence which comprises CDR-L1 which comprises the amino acid sequence set forth in SEQ ID NO: 5, CDR-L2 which comprises the amino acid sequence set forth in SEQ ID NO: 6 and CDR-L3 which comprises the amino acid sequence set forth in SEQ ID NO: 7; and a heavy chain immunoglobulin amino acid sequence which comprises CDR-H1 which comprises the amino acid sequence set forth in SEQ ID NO: 8 or 12 , CDR-H2 which comprises the amino acid sequence set forth in SEQ ID NO: 9 and CDR-H3 which comprises the amino acid sequence set forth in SEQ ID NO: 10; or both; in association with (b) one or more chemotherapeutic agents selected from the group defined in the specification.
Patent NZ-550967-A (NZ)
Title: MAGE-3 and NY-ESO-1 based polyvalent vaccine for cancer immunotherapy
Inventor: BRUCK CLAUDINE ELVIRE MARIE
IPC: A61K39/00
Filed: 2005-05-02
Abstract: Disclosed is a vaccine composition comprising (a) an antigen component comprising a combination of: a MAGE-3 polypeptide linked to a heterologous partner; and an NY-ESO-1 antigen or derivative thereof; and (b) an adjuvant component comprising an immunostimulatory adjuvant comprising one or more of: alum salt; cholesterol; oil-in-water emulsion (OIW emulsion); oil-in water emulsion low dose; an immunostimulatory oligonucleotide; tocopherol; Iiposome; a saponin; and a lipopolysaccharide.
Patent NZ-552643-A (NZ)
Title: A method and apparatus for measuring the phase shift induced in a light signal by a sample
Inventor: AASMUL SOREN
IPC: G01N21/64
Filed: 2005-07-27
Abstract: Apparatus for measuring a phase shift induced in a light signal has a first light source for emitting a light signal along a measurement optical path that includes a sample, for example a fluorescent sample, and a second light source for emitting a light signal along a dummy measurement optical path. A measurement electronic circuit is provided for receiving the light signals from the both measurement optical path and providing outputs separated in time which are indicative of the phase of the respective light signals. In use, a phase shift is induced in light in the measurement optical path by the fluorescent sample. A reference electronic circuit is provided for receiving a signal indicative of the phase of the light signals emitted by the first and second light sources. Circuitry is provided to compare the respective phases of light output from the two circuits to provide an output indicative of a first measured phase difference during operation of the first light source. A correction is then applied to this measurement by taking a similar phase difference measurement during operation of the second light source and comparing the two phase differences.
Patent NZ-553745-A (NZ)
Title: Cytotherapeutic units comprising CD34-, OCT-4+ postpartum placental cells and methods of using such in the manufacture of medicaments
Inventor: HARIRI ROBERT J
Filed: 2003-11-25
Abstract: Disclosed is a cytotherapeutic unit comprising human CD34-, OCT-4+ stem cells obtained from postpartum placental perfusate. The content of said unit is known with respect to the identities and numbers of the cells by being assayed. Further disclosed are kits containing the units, libraries, and uses of the units in the manufacture of medicaments.
Patent NZ-568641-A (NZ)
Title: Fluidtight slide fastener having slider with wedge-shaped cross section and closing stop comprising two half portions
Inventor: COSSUTTI LIVIO
IPC: A44B19/32
Filed: 2007-04-02
Abstract: A slide fastener (10) that is impermeable to fluids and a closing stop for the slide fastener are disclosed. The fastener has a pair of tapes (12) each made of a textile material coated with a fluid barrier material layer. The tapes have aligned sets (20) of teeth (21) and a slider (22) is slideable between an opening stop (24) and a closing stop (26) for engaging the teeth in a fluidtight manner or disengaging the teeth. The slider has an external plate and an internal plate embracing together the sets of aligned teeth, and a middle portion of wedge-shaped cross section positioned between the plates. The closing stop has two half portions, each applied on a respective tape. Each half-portion has a half wedge-shaped recess so that together the half-portions form a housing that match the dimensions of the middle portion of the slider when the slider sops in its closing stroke.
Patent NZ-571537-A (NZ)
Title: Stabilized pentosan polysulfate (PPS) formulations and methods of analayzing them
Inventor: ELLINGHUYSEN JERRY A
IPC: A61K47/26
Filed: 2007-04-03
Abstract: The disclosure relates to a pharmaceutical formulation comprising: (a) pentosan polysulfate (PPS) or a salt thereof, and (b) a buffer, which preferably comprises at least one of citrate, sodium hydroxide/levulinic acid, acetate, bicarbonate, bisulfite, sodium hydroxide/glycine, and phosphate,wherein the formulation is stable without refrigeration and wherein the formulation is substantially free of brown impurities after terminal sterilization.
Patent NZ-571673-A (NZ)
Title: A pyrazolopyrimidinone derivative for the prevention and treatment of prostatic hyperplasia
Inventor: YU JAE YOUNG
IPC: A61P13/08
Filed: 2006-04-04
Abstract: The disclosure relates to the use of a compound of formula (1) as an agent for preventing and treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) associated with BPH and a relaxant for relaxing urethral smooth muscle or prostatic smooth muscle comprising a pyrazolopyrimidinone compound as an effective ingredient. Said agent can provide nitric oxides by inhibiting the activity of PDE-5 that decomposes c-GMP, and the provided nitric oxides relax the urethral smooth muscle or the prostatic smooth muscle to lower the intraurethral pressure (IUP), thus treating BPH and LUTS associated with BPH. Furthermore, the time required for reaching a maximum blood concentration is shorter and the half-life is longer than the other PDE-5 inhibitors, thus reducing the frequency of administration. Moreover, the agent causing few side effects can be efficiently used as a safe drug.